Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
about
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@ast
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@en
type
label
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@ast
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@en
prefLabel
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@ast
Epstein-Barr Virus Specific An ...... nths of Natalizumab Treatment.
@en
P2860
P50
P356
P1433
P1476
Epstein-Barr Virus Specific An ...... onths of Natalizumab Treatment
@en
P2093
Francesca Elia
Matteo Gastaldi
P2860
P304
P356
10.1155/2015/901312
P50
P577
2015-05-26T00:00:00Z